Successful pharmaceutical manufacturing strategies depend on raw materials that are of good quality. While much effort is spent to develop the pharma raw materials, quality still remains a daunting challenge in front of the industry. Moreover, rising competition, changing regulatory requirements, and supply chain disruption has jeopardized the procurement strategies of the pharma players. Today, obtaining quality assured raw materials at a cost-efficient rate has developed into a Sisyphean task. In this hour, a knowledgeable pharma raw material manufacturer with an impeccable technical expertis becomes an invaluable asset for the pharma companies. This is where TKS Saraswati Lab comes into the picture. As a research-based entity, TKS Saraswati Lab strives to devise innovative avenues for meeting the exacting demands of its clients with absolute precision. Along with the development of APIs and Intermediaries, the firm now excels in delivering crucial services to its clients, such as, custom Synthesis, Isolation of impurities from API, and more. Owing to the firm's undivided attention towards quality, it has also been accredited ISO 9001:2015 certification. “At TKS Saraswati Lab, our core strength lies in the cutting-edge technology and highly qualified staff. Our knowledge and dedication, transforms us into an impeccable force allowing us to develop every product that is produced at any corner of the globe”, says Dr. Narendra Karambelkar, Director- Business Development at TKS Saraswati Lab.
Two Pillars
Since inception, TKS Saraswati Lab has devoted its attention to continually upgrading its infrastructure while developing a robust workforce. Furthermore, Dr. Narendra Karambelkar's experience as a pharma lab development consultant gives the company an added advantage to be on par with international standards. Starting with R&D, TKS now has a well-established and technologically sophisticated Research and Development center that is capable of addressing a variety of developmental challenges in the areas of impurity synthesis, APIs, and intermediates process development. Presently, the cutting-edge infrastructure at TKS includes, process development and scale-up labs, facility to put high (300° Celsius) and low (85° Celsius) temperature reaction, high pressure reactors, and others. The dedicated analytical and synthetic chemistry labs help the firm to attain high purity. Moreover, the team has also installed self-packing devices that aid in performing multiple tests at a faster pace to attain higher quality products. “Recently, one of our clients came to us with a criterion to attain 90 percent purity for certain products. However, with our infrastructure and knowledge, we attained a purity nearing 100 percent", states Dr. Narendra Karambelkar.
The proficient workforce at TKS has been its X-factor, propelling the growth of the organization. The handpicked group of experts at TKS comprises numerous Masters’ degree and PhD holders possessing a wide experience of developing and contributing to the quality research and quality products. “There are numerous firms that attain 100 or 200 percent of our turnover. However, in numerous instances these firms approach us to solve a complexproblem for them. In a nutshell, our uniqueness lies in our in-depth domain knowledge”, mentions Dr. Narendra Kamblekar.
Our Knowledge And Dedication, Transforms Us Into An Impeccable Force Allowing Us To Develop Every Product That Is Produced At Any Corner Of The Globe
Roadmap Ahead
TKS has numerous endeavors in mind for the days ahead. The team is now working to set up one new laboratory that will be on par with GMP and GLP norms. Moreover, Dr. Karambelkar also wants TKS to evolve as a pharma contract manufacturer. He is looking forward to setting-up his own plant within the next few years. He further desires to get patents, and develop new & innovative technologies that will guide the pharma industry towards a better future.
.jpg "Overcoming the Hurdles of Scaling a Startup")
We use cookies to ensure you get the best experience on our website. Read more...
